C12N 2770/24022
New viral proteins or individual genes, new structural or functional aspects of
Official title: New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
C12N2770/24022 (New viral proteins or individual genes, new structural or functional aspects of) appears on 74 US grants and 67 published applications in this corpus.
Search patents in C12N- Granted patents
- 74
- Published applications
- 67
- Assignees
- 50
- Inventors
- 129
- Latest grant
- 28 Jun 2022
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1994 | 1 | 0 |
| 1995 | 1 | 0 |
| 1996 | 2 | 0 |
| 1997 | 2 | 0 |
| 1998 | 6 | 0 |
| 1999 | 3 | 0 |
| 2000 | 4 | 0 |
| 2001 | 4 | 0 |
| 2002 | 1 | 1 |
| 2003 | 2 | 6 |
| 2004 | 1 | 2 |
| 2005 | 2 | 5 |
| 2006 | 2 | 6 |
| 2007 | 6 | 4 |
| 2008 | 4 | 7 |
| 2009 | 3 | 3 |
| 2010 | 4 | 6 |
| 2011 | 1 | 5 |
| 2012 | 7 | 2 |
| 2013 | 2 | 0 |
| 2014 | 5 | 2 |
| 2015 | 0 | 4 |
| 2016 | 2 | 2 |
| 2017 | 3 | 1 |
| 2018 | 1 | 1 |
| 2019 | 1 | 1 |
| 2020 | 1 | 3 |
| 2021 | 2 | 1 |
| 2022 | 1 | 1 |
| 2023 | 0 | 1 |
| 2024 | 0 | 2 |
| 2025 | 0 | 0 |
| 2026 | 0 | 1 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Neutralizing antibodies that bind to the zika virus domain III envelope region28 Jun 2022US 11,370,830 B2The Rockefeller University
- Zika as a cell penetrating peptide for delivery to the brain20 Jul 2021US 11,066,448 B2Buck Institute for Research on Aging
- Zika virus vaccines9 Feb 2021US 10,913,776 B2University of Pittsburgh—Of the Commonwealth System of Higher Education
- 2′-branched nucleosides and flaviviridae mutation7 Jan 2020US 10,525,072 B2Idenix Pharmaceuticals, Inc.
- Compositions and methods for detecting human pegivirus 2 (HPgV-2)10 Dec 2019US 10,501,816 B2Abbott Laboratories
- Orally-delivered vaccines for domesticated and wild animals to prevent pathogen spread using recombinant probiotic bacteria1 Oct 2026US 2026/0295027 A1
- Recombinant classical swine fever virus e2 protein24 Oct 2024US 2024/0350610 A1Boehringer Ingelheim Vetmedica (China) Co., Ltd.
- Bacteriophage virus-like particle vaccines against flavivirus non-structural protein 126 Sep 2024US 2024/0316174 A1UNM Rainforest Innovations
- Combinations of flavivirus proteins, peptide sequences, epitopes, and methods and uses thereof18 May 2023US 2023/0149526 A1La Jolla Institute for Immunology
- Neutralizing antibodies that bind to the zika virus domain iii envelope region29 Sep 2022US 2022/0306729 A1The Rockefeller University
Most cited
By later US patents
- Recombinant infectious non-segmented negative strand RNA virus156US 6,033,886 A2000
- Canarypox virus expressing cytokine and/or tumor-associated antigen DNA sequence128US 5,833,975 AVirogenetics Corporation · 1998
- Genetically engineered vaccine strain89US 5,364,773 AVirogenetics Corporation · 1994
- Pox virus containing DNA encoding a cytokine and/or a tumor associated antigen89US 6,265,189 B1Virogenetics Corporation · 2001
- 2′-branched nucleosides and Flaviviridae mutation59US 7,824,851 B2Idenix Pharmaceuticals, Inc. · 2010